Boston Scientific Corporation
BSX
$51.34
$0.881.74%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.44B | 5.20B | 5.29B | 5.07B | 5.06B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.44B | 5.20B | 5.29B | 5.07B | 5.06B |
| Cost of Revenue | 1.61B | 1.60B | 1.61B | 1.54B | 1.65B |
| Gross Profit | 3.84B | 3.60B | 3.67B | 3.53B | 3.41B |
| SG&A Expenses | 1.80B | 1.78B | 1.83B | 1.74B | 1.72B |
| Depreciation & Amortization | 233.00M | 232.00M | 228.00M | 225.00M | 225.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.20B | 4.13B | 4.25B | 4.02B | 4.12B |
| Operating Income | 1.25B | 1.07B | 1.04B | 1.05B | 943.00M |
| Income Before Tax | 1.06B | 1.16B | 700.00M | 938.00M | 941.00M |
| Income Tax Expenses | 155.00M | -176.00M | 30.00M | 183.00M | 146.00M |
| Earnings from Continuing Operations | 905.00M | 1.34B | 670.00M | 755.00M | 795.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.00M | 2.00M | 2.00M | -- | 2.00M |
| Net Income | 907.00M | 1.34B | 672.00M | 755.00M | 797.00M |
| EBIT | 1.25B | 1.07B | 1.04B | 1.05B | 943.00M |
| EBITDA | 1.60B | 1.42B | 1.41B | 1.39B | 1.28B |
| EPS Basic | 0.62 | 0.90 | 0.45 | 0.51 | 0.54 |
| Normalized Basic EPS | 0.49 | 0.42 | 0.43 | 0.39 | 0.36 |
| EPS Diluted | 0.61 | 0.90 | 0.45 | 0.51 | 0.53 |
| Normalized Diluted EPS | 0.48 | 0.42 | 0.42 | 0.39 | 0.36 |
| Average Basic Shares Outstanding | 1.47B | 1.48B | 1.48B | 1.48B | 1.48B |
| Average Diluted Shares Outstanding | 1.47B | 1.50B | 1.50B | 1.50B | 1.49B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |